This book provides a comprehensive exploration of the transformative potential of Artificial Intelligence (AI) in haemostatic pharmacology within the United Kingdom. It bridges the gap between complex scientific research and practical applications, making it accessible to healthcare professionals, researchers, and anyone interested in the future of medicine. Showcasing innovative AI-driven diagnostic tools, predictive models for bleeding risk, and novel drug development strategies, it highlights the UK's contributions to this burgeoning field, featuring local research institutions, pharmaceutical companies, and healthcare providers at the forefront of innovation. By exploring the challenges and ethical considerations, this book fosters informed discussions and collaborations that will drive advancements in haemostatic care. It serves as a valuable resource for policymakers and stakeholders interested in understanding the transformative potential of AI in healthcare, inspiring further research, development, and implementation of AI-powered solutions to improve patient outcomes and reduce the burden of bleeding and thrombotic disorders on the UK healthcare system.